Hidemi S. Yamamoto

发表

Endobiont Viruses Sensed by the Human Host – Beyond Conventional Antiparasitic Therapy

Russell P. Goodman, M. Nibert, Y. Takagi, 2012, PloS one.

Urinary intestinal fatty acid binding protein predicts necrotizing enterocolitis.

R. Fichorova, K. Gregory, Hidemi S. Yamamoto, 2014, Jornal de Pediatria.

Persistence after birth of systemic inflammation associated with umbilical cord inflammation.

A. Leviton, R. Fichorova, O. Dammann, 2011, Journal of reproductive immunology.

Puerperal mastitis: a reproductive event of importance affecting anti-mucin antibody levels and ovarian cancer risk

L. Titus, D. Cramer, W. Welch, 2013, Cancer Causes & Control.

Novel Vaginal Microflora Colonization Model Providing New Insight into Microbicide Mechanism of Action

G. Doncel, R. Fichorova, A. Onderdonk, 2011, mBio.

Intestinal Inflammation is Significantly Associated With Length Faltering in Preterm Infants at Neonatal Intensive Care Unit Discharge

R. Fichorova, K. Gregory, S. Cherkerzian, 2022, Journal of pediatric gastroenterology and nutrition.

Urinary Excretion of C5b‐9 is Associated With the Anti‐Angiogenic State in Severe Preeclampsia

R. Fichorova, Stephanie H. Guseh, Hidemi S. Yamamoto, 2015, American journal of reproductive immunology.

Ovarian cancer early detection by circulating CA125 in the context of anti‐CA125 autoantibody levels: Results from the EPIC cohort

E. Riboli, C. la Vecchia, A. Tjønneland, 2018, International journal of cancer.

Homeostatic properties of Lactobacillus jensenii engineered as a live vaginal anti-HIV microbicide

Qiang Xu, R. Fichorova, Hidemi S. Yamamoto, 2013, BMC Microbiology.

Systemic Inflammation in the Extremely Low Gestational Age Newborn Following Maternal Genitourinary Infections

A. Leviton, R. Fichorova, E. Allred, 2015, American journal of reproductive immunology.

Surfactant Protein D Reverses the Gene Signature of Transepithelial HIV-1 Passage and Restricts the Viral Transfer Across the Vaginal Barrier

R. Fichorova, U. Kishore, Madavan Vasudevan, 2019, Front. Immunol..

Elevated Intestinal Inflammation in Preterm Infants With Signs and Symptoms of Gastroesophageal Reflux Disease

R. Fichorova, K. Gregory, Hidemi S. Yamamoto, 2021, Biological research for nursing.

Racial/ethnic differences in average CA125 and CA15.3 values and its correlates among postmenopausal women in the U.S.

D. Cramer, A. Vitonis, R. Fichorova, 2021 .

The Role of Small Extracellular Vesicles in Viral-Protozoan Symbiosis: Lessons From Trichomonasvirus in an Isogenic Host Parasite Model

B. Budnik, R. Fichorova, Hidemi S. Yamamoto, 2020, Frontiers in Cellular and Infection Microbiology.

The Villain Team-Up or how Trichomonas vaginalis and bacterial vaginosis alter innate immunity in concert

M. Nibert, Y. Takagi, R. Fichorova, 2013, Sexually Transmitted Infections.

Vascular endothelial growth factors and their receptors and regulators in gestational trophoblastic diseases and normal placenta.

R. Berkowitz, S. Ng, R. Fichorova, 2012, The Journal of reproductive medicine.

Epidemiologic and biologic correlates of serum HE4 and CA125 in women from the National Health and Nutritional Survey (NHANES).

D. Cramer, A. Vitonis, R. Fichorova, 2021, Gynecologic oncology.

Complement Activation and Kidney Injury Molecule-1–Associated Proximal Tubule Injury in Severe Preeclampsia

R. Fichorova, Hidemi S. Yamamoto, H. Dawood, 2014, Hypertension.

Antecedents and correlates of blood concentrations of neurotrophic growth factors in very preterm newborns

M. O'Shea, A. Leviton, R. Fichorova, 2017, Cytokine.

Maternal Microbe-Specific Modulation of Inflammatory Response in Extremely Low-Gestational-Age Newborns

A. Leviton, R. Fichorova, E. Allred, 2011, mBio.

Relationships among the concentrations of 25 inflammation-associated proteins during the first postnatal weeks in the blood of infants born before the 28th week of gestation.

A. Leviton, R. Fichorova, E. Allred, 2012, Cytokine.

Matrix metalloproteinases and their inhibitors and inducer in gestational trophoblastic diseases and normal placenta.

R. Berkowitz, S. Ng, R. Fichorova, 2011, Gynecologic oncology.

The Villain Team-Up or how Trichomonas vaginalis and bacterial vaginosis alter innate immunity in concert

M. Nibert, Y. Takagi, R. Fichorova, 2013, Sexually Transmitted Infections.

Protozoan-Viral-Bacterial Co-Infections Alter Galectin Levels and Associated Immunity Mediators in the Female Genital Tract

D. Vlahov, J. Sobel, R. Fichorova, 2021, Frontiers in Cellular and Infection Microbiology.

Aberrant cervical innate immunity predicts onset of dysbiosis and sexually transmitted infections in women of reproductive age

C. Morrison, Pai-Lien Chen, C. Kwok, 2020, PloS one.

Cervicovaginal bacteria are a major modulator of host inflammatory responses in the female genital tract.

Melis N. Anahtar, C. Nusbaum, C. Huttenhower, 2015, Immunity.

Gene Expression Profiling of Human Vaginal Cells In Vitro Discriminates Compounds with Pro-Inflammatory and Mucosa-Altering Properties: Novel Biomarkers for Preclinical Testing of HIV Microbicide Candidates

Jasmin H. Bavarva, G. Doncel, J. Bavarva, 2015, PloS one.

Trichomonas vaginalis Lipophosphoglycan Exploits Binding to Galectin-1 and -3 to Modulate Epithelial Immunity

R. Fichorova, Hidemi S. Yamamoto, G. R. Hayes, 2015, The Journal of Biological Chemistry.

Urinary Excretion of C5b-9 in Severe Preeclampsia: Tipping the Balance of Complement Activation in Pregnancy

R. Fichorova, Hidemi S. Yamamoto, H. Dawood, 2013, Hypertension.

A Prospective Evaluation of Early Detection Biomarkers for Ovarian Cancer in the European EPIC Cohort

I. Gram, E. Riboli, A. Tjønneland, 2016, Clinical Cancer Research.